379 related articles for article (PubMed ID: 25619822)
21. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K
Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.
Sunduru N; Nishi ; Palne S; Chauhan PM; Gupta S
Eur J Med Chem; 2009 Jun; 44(6):2473-81. PubMed ID: 19217698
[TBL] [Abstract][Full Text] [Related]
23. Spinigerin induces apoptotic like cell death in a caspase independent manner in Leishmania donovani.
Sardar AH; Das S; Agnihorti S; Kumar M; Ghosh AK; Abhishek K; Kumar A; Purkait B; Ansari MY; Das P
Exp Parasitol; 2013 Dec; 135(4):715-25. PubMed ID: 24184774
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of 2-(pyrimidin-2-yl)-1-phenyl-2,3,4,9-tetrahydro-1H-beta-carbolines as antileishmanial agents.
Kumar R; Khan S; Verma A; Srivastava S; Viswakarma P; Gupta S; Meena S; Singh N; Sarkar J; Chauhan PM
Eur J Med Chem; 2010 Aug; 45(8):3274-80. PubMed ID: 20457476
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo antileishmanial efficacy of a new nitrilquinoline against Leishmania donovani.
Nakayama H; Desrivot J; Bories C; Franck X; Figadère B; Hocquemiller R; Fournet A; Loiseau PM
Biomed Pharmacother; 2007; 61(2-3):186-8. PubMed ID: 17360145
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani.
Keurulainen L; Siiskonen A; Nasereddin A; Kopelyanskiy D; Sacerdoti-Sierra N; Leino TO; Tammela P; Yli-Kauhaluoma J; Jaffe CL; Kiuru P
Bioorg Med Chem Lett; 2015 May; 25(9):1933-7. PubMed ID: 25827525
[TBL] [Abstract][Full Text] [Related]
27. Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series.
Kieffer C; Cohen A; Verhaeghe P; Hutter S; Castera-Ducros C; Laget M; Remusat V; M'Rabet MK; Rault S; Rathelot P; Azas N; Vanelle P
Eur J Med Chem; 2015 Mar; 92():282-94. PubMed ID: 25559208
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of N-(1-methyl-1H-indol-3-yl)methyleneamines and 3,3-diaryl-4-(1-methyl-1H-indol-3-yl)azetidin-2-ones as potential antileishmanial agents.
Singh GS; Al-Kahraman YM; Mpadi D; Yasinzai M
Bioorg Med Chem Lett; 2012 Sep; 22(17):5704-6. PubMed ID: 22832310
[TBL] [Abstract][Full Text] [Related]
29. A Novel Spirooxindole Derivative Inhibits the Growth of Leishmania donovani Parasites both In Vitro and In Vivo by Targeting Type IB Topoisomerase.
Saha S; Acharya C; Pal U; Chowdhury SR; Sarkar K; Maiti NC; Jaisankar P; Majumder HK
Antimicrob Agents Chemother; 2016 Oct; 60(10):6281-93. PubMed ID: 27503653
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of perspicamide A and related diverse analogues: their bioevaluation as potent antileishmanial agents.
Pandey AK; Sharma R; Shivahare R; Arora A; Rastogi N; Gupta S; Chauhan PM
J Org Chem; 2013 Feb; 78(4):1534-46. PubMed ID: 23289499
[TBL] [Abstract][Full Text] [Related]
31. Antileishmanial and immunomodulatory activities of lupeol, a triterpene compound isolated from Sterculia villosa.
Das A; Jawed JJ; Das MC; Sandhu P; De UC; Dinda B; Akhter Y; Bhattacharjee S
Int J Antimicrob Agents; 2017 Oct; 50(4):512-522. PubMed ID: 28669838
[TBL] [Abstract][Full Text] [Related]
32. Click chemistry decoration of amino sterols as promising strategy to developed new leishmanicidal drugs.
Porta EO; Carvalho PB; Avery MA; Tekwani BL; Labadie GR
Steroids; 2014 Jan; 79():28-36. PubMed ID: 24200958
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents.
Esteves MA; Fragiadaki I; Lopes R; Scoulica E; Cruz ME
Bioorg Med Chem; 2010 Jan; 18(1):274-81. PubMed ID: 19926293
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy of leishmaniasis part-VIII: synthesis and bioevaluation of novel chalcones.
Suryawanshi SN; Chandra N; Kumar P; Porwal J; Gupta S
Eur J Med Chem; 2008 Nov; 43(11):2473-8. PubMed ID: 18243420
[TBL] [Abstract][Full Text] [Related]
35. Discovery of a new antileishmanial hit in 8-nitroquinoline series.
Paloque L; Verhaeghe P; Casanova M; Castera-Ducros C; Dumètre A; Mbatchi L; Hutter S; Kraiem-M'rabet M; Laget M; Remusat V; Rault S; Rathelot P; Azas N; Vanelle P
Eur J Med Chem; 2012 Aug; 54():75-86. PubMed ID: 22608675
[TBL] [Abstract][Full Text] [Related]
36. Activity of a novel sulfonamide compound 2-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide against Leishmania donovani.
Dikhit MR; Purkait B; Singh R; Sahoo BR; Kumar A; Kar RK; Ansari MY; Saini S; Abhishek K; Sahoo GC; Das S; Das P
Drug Des Devel Ther; 2016; 10():1753-61. PubMed ID: 27307706
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antileishmanial activity of piperoyl-amino acid conjugates.
Singh IP; Jain SK; Kaur A; Singh S; Kumar R; Garg P; Sharma SS; Arora SK
Eur J Med Chem; 2010 Aug; 45(8):3439-45. PubMed ID: 20546981
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives.
Peyron C; Benhida R; Bories C; Loiseau PM
Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460
[TBL] [Abstract][Full Text] [Related]
39. Exploration of antileishmanial activity in heterocycles; results of their in vivo & in vitro bioevaluations.
Bhatnagar S; Guru PY; Katiyar JC; Srivastava R; Mukherjee A; Akhtar MS; Seth M; Bhaduri AP
Indian J Med Res; 1989 Nov; 89():439-44. PubMed ID: 2620947
[TBL] [Abstract][Full Text] [Related]
40. Oxysterols: Synthesis and anti-leishmanial activities.
Ghosh P; Ghosh A; Mandal A; Sultana SS; Dey S; Pal C
Steroids; 2016 Mar; 107():65-73. PubMed ID: 26742629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
